Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052829811> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2052829811 endingPage "775" @default.
- W2052829811 startingPage "769" @default.
- W2052829811 abstract "A 24-h extended-release formulation of fexofenadine HCl 180 mg/pseudoephedrine HCl 240 mg (FEX 180 mg/PSE 240 mg) has recently been approved by the US Food and Drug Administration for symptom relief of seasonal allergic rhinitis, including nasal congestion. When considering a combination formulation, it is important to confirm that the metabolism and pharmacokinetics of the drugs remain unchanged when combined. Thus, the aim of this study was to evaluate single-dose and steady-state bioequivalence of FEX 180 mg/PSE 240 mg 24-h compared with the individual formulations taken concurrently.This was an open-label, randomized, two-treatment, two-period, 10-day, crossover study. In Treatment A, healthy subjects received a single, oral dose of FEX 180 mg/PSE 240 mg combination tablet on Day 1 followed by 6 days of once-daily dosing beginning on Day 4. Participants in Treatment B were concurrently administered a single oral dose of FEX 180 mg immediate-release tablet and a PSE 240 mg extended-release tablet with a similar dosing schedule. After an 8-day washout period, subjects crossed over to the alternate treatment. Plasma concentrations of FEX and PSE were determined using high-performance liquid chromatography/mass spectrometry.Pharmacokinetic parameters AUC0-infinity1 and Cmax1 following a single-dose (Day 1, dose 1), Cmax7, AUC0-24(7) at steady-state and Cmin7 measured at the end of the dosing interval (Day 9, dose 7) revealed bioequivalence between FEX 180 mg/PSE 240 mg combination tablet and the individual components taken concurrently. The 90% confidence intervals for the treatment ratios fell entirely within the bioequivalence range (80% to 125%). The combination tablet was well tolerated by all subjects, with a safety profile comparable to the individual components.These findings demonstrate that the pharmacokinetics of the new 24-h FEX 180 mg/PSE 240 mg combination formulation are bioequivalent to the concurrent administration of the individual drug components. Furthermore, both treatments were well tolerated in this population." @default.
- W2052829811 created "2016-06-24" @default.
- W2052829811 creator A5023930801 @default.
- W2052829811 creator A5030361853 @default.
- W2052829811 creator A5038366227 @default.
- W2052829811 creator A5075318365 @default.
- W2052829811 date "2005-04-20" @default.
- W2052829811 modified "2023-10-14" @default.
- W2052829811 title "Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults" @default.
- W2052829811 cites W1976690237 @default.
- W2052829811 cites W1983331153 @default.
- W2052829811 cites W2005113167 @default.
- W2052829811 cites W2017042189 @default.
- W2052829811 cites W2031199458 @default.
- W2052829811 cites W2051041212 @default.
- W2052829811 cites W2053231991 @default.
- W2052829811 cites W2061564002 @default.
- W2052829811 cites W2063390971 @default.
- W2052829811 cites W2076401767 @default.
- W2052829811 cites W2149609246 @default.
- W2052829811 cites W2156127295 @default.
- W2052829811 cites W2162078684 @default.
- W2052829811 cites W2169335265 @default.
- W2052829811 cites W2417442871 @default.
- W2052829811 cites W4246491864 @default.
- W2052829811 cites W4254522705 @default.
- W2052829811 doi "https://doi.org/10.1185/030079905x43703" @default.
- W2052829811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15969876" @default.
- W2052829811 hasPublicationYear "2005" @default.
- W2052829811 type Work @default.
- W2052829811 sameAs 2052829811 @default.
- W2052829811 citedByCount "8" @default.
- W2052829811 countsByYear W20528298112015 @default.
- W2052829811 countsByYear W20528298112016 @default.
- W2052829811 countsByYear W20528298112017 @default.
- W2052829811 countsByYear W20528298112022 @default.
- W2052829811 crossrefType "journal-article" @default.
- W2052829811 hasAuthorship W2052829811A5023930801 @default.
- W2052829811 hasAuthorship W2052829811A5030361853 @default.
- W2052829811 hasAuthorship W2052829811A5038366227 @default.
- W2052829811 hasAuthorship W2052829811A5075318365 @default.
- W2052829811 hasConcept C112705442 @default.
- W2052829811 hasConcept C142724271 @default.
- W2052829811 hasConcept C204787440 @default.
- W2052829811 hasConcept C22979827 @default.
- W2052829811 hasConcept C27081682 @default.
- W2052829811 hasConcept C2776711289 @default.
- W2052829811 hasConcept C2777056448 @default.
- W2052829811 hasConcept C2777288759 @default.
- W2052829811 hasConcept C2778984665 @default.
- W2052829811 hasConcept C2779777004 @default.
- W2052829811 hasConcept C42404028 @default.
- W2052829811 hasConcept C71924100 @default.
- W2052829811 hasConcept C87813604 @default.
- W2052829811 hasConcept C98274493 @default.
- W2052829811 hasConceptScore W2052829811C112705442 @default.
- W2052829811 hasConceptScore W2052829811C142724271 @default.
- W2052829811 hasConceptScore W2052829811C204787440 @default.
- W2052829811 hasConceptScore W2052829811C22979827 @default.
- W2052829811 hasConceptScore W2052829811C27081682 @default.
- W2052829811 hasConceptScore W2052829811C2776711289 @default.
- W2052829811 hasConceptScore W2052829811C2777056448 @default.
- W2052829811 hasConceptScore W2052829811C2777288759 @default.
- W2052829811 hasConceptScore W2052829811C2778984665 @default.
- W2052829811 hasConceptScore W2052829811C2779777004 @default.
- W2052829811 hasConceptScore W2052829811C42404028 @default.
- W2052829811 hasConceptScore W2052829811C71924100 @default.
- W2052829811 hasConceptScore W2052829811C87813604 @default.
- W2052829811 hasConceptScore W2052829811C98274493 @default.
- W2052829811 hasIssue "5" @default.
- W2052829811 hasLocation W20528298111 @default.
- W2052829811 hasLocation W20528298112 @default.
- W2052829811 hasOpenAccess W2052829811 @default.
- W2052829811 hasPrimaryLocation W20528298111 @default.
- W2052829811 hasRelatedWork W2018313535 @default.
- W2052829811 hasRelatedWork W2033685750 @default.
- W2052829811 hasRelatedWork W2053536280 @default.
- W2052829811 hasRelatedWork W2055974197 @default.
- W2052829811 hasRelatedWork W2056422086 @default.
- W2052829811 hasRelatedWork W2092883996 @default.
- W2052829811 hasRelatedWork W2312656931 @default.
- W2052829811 hasRelatedWork W2349338867 @default.
- W2052829811 hasRelatedWork W2385472588 @default.
- W2052829811 hasRelatedWork W4242988102 @default.
- W2052829811 hasVolume "21" @default.
- W2052829811 isParatext "false" @default.
- W2052829811 isRetracted "false" @default.
- W2052829811 magId "2052829811" @default.
- W2052829811 workType "article" @default.